A privately held company
Murray Goldman
Mediqventures
JamJar Investments
Berti Investments
Noetic Psychedelic Fund
Seven Hound Ventures
Explorer Equity Group
Chris Kantrowitz
Negev Capital
Iter Investments
Cosmo Feilding Mellen
Director & CEO
Amanda Feilding
Director & Chair of Scientific Advisory Board
Steve Wooding
Chief Scientific Officer
Fiona Dunbar
Chief Medical Advisor
Tim Mason
Chief Development Officer
Michael Norris
Director & Chief Financial Officer
Kalpana Sawant
Director of Clinical Operations
Becky Verity
Commercial Director
Ian MacLeod
Clinical Project Manager
Amir Lotfi
Research & Development Scientist
Anya Ermakova
Research Scientist
Kasia Kubow
Study Management Associate
Marc Wayne
Chairman
Denham Eke
Investor Director
Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)
Beckley Waves
MagicMed Industries
IntelGenx
Mera Life Sciences
XPhyto
CURE Pharmaceutical
Mycrodose Therapeutics